type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with type 2 diabetes whose age at the time of obtaining consent is 20 to 80 years old. 2. Hospitalized type 2 diabetic patients. (HbA1c 6.5% or more) 3. Patients with written informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients taking an a-glucosidase inhibitor 2. Patients with a history of serious side effects after taking D-allulose in the past 3. Pregnant, maternity, lactating or potentially pregnant women 4. Patients with severe renal impairment (serum creatinine level of 1.5 mg/dl or higher) 5. Patients with other serious complications 6. Patients participating in other trials 7. According to the opinion of the investigator, etc., if participation in the research does not maximize the benefit of the research target (such as impairing the welfare of the research target), or obstructing, limiting, or confusing the evaluation specific to the clinical research implementation plan. If it is determined to do. 8. Under the direction of the investigator, etc. or the conducting medical institution, the investigator of the investigator or the conducting medical institution directly involved in this research or other clinical research, or such employee or the investigator Family
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The postprandial blood glucose peak value is comparatively examined using a Flash Glucose Monitoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| AUC 2 hours after meal when using continuous blood glucose meter Blood/urine D allulose concentration Questionnaire of patient satisfaction including seasoning Change in weight change Control status of diabetes before and after ingestion of each diet group Changes in various laboratory test values | — |
Contacts
Kagawa University hospital